Frequency and prognostic impact of IDH2 gene mutations in CN-AML
| Reference . | n . | Age range, y . | IDH2R172 mutation . | IDH2R140 mutation . | ||
|---|---|---|---|---|---|---|
| Frequency . | Prognosis . | Frequency . | Prognosis . | |||
| Marcucci et al3 | 358 | 19-83 | 4% | ↓ CR | 16% | NC |
| Thol et al7 | 272 | ≤ 60 | 1.1% | No impact† | 11% | No impact† |
| Paschka et al4 | 338 | 16-60 | NC | NC | NC | NC |
| Boissel et al5 | 213 | 17-70 | 6% | ↓ CR, ↑ RR, ↓ OS | — | — |
| Abbas et al8 | 353 | 15-77 | 14%† | No impact† | 14%† | No impact† |
| Chou et al9 | 155‡ | 18-90 | NC | ↑ OS | NC | ↑ OS |
| Reference . | n . | Age range, y . | IDH2R172 mutation . | IDH2R140 mutation . | ||
|---|---|---|---|---|---|---|
| Frequency . | Prognosis . | Frequency . | Prognosis . | |||
| Marcucci et al3 | 358 | 19-83 | 4% | ↓ CR | 16% | NC |
| Thol et al7 | 272 | ≤ 60 | 1.1% | No impact† | 11% | No impact† |
| Paschka et al4 | 338 | 16-60 | NC | NC | NC | NC |
| Boissel et al5 | 213 | 17-70 | 6% | ↓ CR, ↑ RR, ↓ OS | — | — |
| Abbas et al8 | 353 | 15-77 | 14%† | No impact† | 14%† | No impact† |
| Chou et al9 | 155‡ | 18-90 | NC | ↑ OS | NC | ↑ OS |